Abstract
approach to other radiopharmaceuticals. Each patient was asked to select a family member, defined as someone who was involved in their care and living at home with them during the course of their treatment, to participate by completing the study survey. There were no other predetermined eligibility criteria for the family members.
Accrual
A survey was used to gather data in this study. A total of 700 survey packages were distributed to physicians in eight clinics or sites across Canada where radioactive iodine therapy was delivered. Sites were selected purposively to reflect cross-Canada settings with major clinical programs delivering radioactive iodine therapy. The location sites included Newfoundland, Nova Scotia, Ontario (two sites), Quebec (two sites), Manitoba, and British Columbia. Ethics approval for the project was obtained from the respective ethics review boards of all sites. In each city, the physician was asked to participate. Upon receipt of the surveys, each of the eight physicians identified, from his or her caseload, 35 patients with a malignant diagnosis and 35 patients with a non-malignant disease who had received I131 treatment within the past two years. Although the I131 treatment was to have been received within the past two years, the actual diagnosis may have occurred a few months prior to the treatment event.
Survey packages were then mailed by the respective clinics to the selected patients. Each package contained a letter of explanation, a copy of the survey, and a pre-stamped return envelope. The patient gave the family member survey to the individual he or she selected. The family member completed the survey at home and returned it to the researcher's office. The researcher was not aware of the patient names or the family member names, and the physicians were not aware who had participated in the study. Given this arrangement requested by the ethics review boards, no follow-up reminders were sent.
Survey instrument
The survey instrument used in this work was developed for the purposes of this study. A patient survey was crafted following indepth interviews with 21 patients who had undergone treatment with I131. Results from the patient survey are reported in a separate publication . The family member survey was crafted to match the content areas of the patient survey. The format of the survey was based on a survey format used successfully with prostate cancer patients (Gray, Klotz, et al., 1997) and ovarian cancer patients (Fitch, Gray, DePetrillo, Franssen, & Howell, 1999) . The survey was reviewed for content or face validity, readability, and clarity by individuals with survey development expertise and expertise in radioactive iodine treatment.
The survey was designed to elicit family members' perspectives regarding the following topic areas: experiences during diagnosis and treatment, including problems experienced and assistance received for problems; access to, importance of, satisfaction with information and communication with health care professionals; impact on the family member; and support. The survey items were precoded with response options generated from the ideas embodied in the indepth interviews. The majority of the items presented a list of response options and the respondents marked those which applied to them. Likert-type scales were used to assess the importance of information and the impact of the diagnosis and treatment on lifestyle. Opportunities to write additional responses were offered throughout the document. This paper reports the data regarding family member perspectives on access to information, experiences during treatment, precautions, impact on the family member, and support. 
Results

Demographic characteristics
A total of 130 family members returned the survey (response rate of 19%). Sixty-eight had had a close relative treated as an inpatient and 62 had a close relative treated as an outpatient. Table One presents the demographic information from the family members in each group. Overall, the respondents had an average age of 46.3 years (range 20 to 82). Half of the respondents were female and 83% were Caucasian. Almost two-thirds were partners (spouses) to the patients who received treatment. The majority had completed high school and half had also completed community college or university. Slightly more than half were working and 14% were retired. Approximately one-third (34%) had an income between $30,000 and $59,999. The respondents were well-distributed across communities ranging from populations of less than 5,000 (22%) and 5,000-49,000 (28%) to 50,000-249,000 (28%). Responses were received from each of the six provinces where surveys were distributed.
Of the family members who had a patient treated as an inpatient, 66% of those patients had malignant disease. Fifty-three per cent of the inpatients had been diagnosed within the last year, while 32% had received their diagnosis between two and three years ago. Of the family members who had had a patient treated as an outpatient, 86% had been diagnosed with non-malignant disease. Half of the outpatient group had received the diagnosis in the past year, while 29% learned of their diagnosis two to three years prior to the survey.
Family members for the inpatient group reported that, in addition to the radioactive iodine treatment, 84% of the patients had undergone a total thyroidectomy. Fifty-nine per cent of these patients underwent a single radioactive iodine treatment. The family members of the outpatient group indicated 50% of the patients had received medication in addition to the radioactive iodine therapy. In this group of patients, 82% experienced a single radioactive iodine treatment.
Access to information
In the six weeks following the patient's diagnosis of a thyroid condition, approximately half of the inpatient family members (54%) and slightly less than half of the outpatient family members (44%) felt they had someone with whom to talk about the diagnosis. Somewhat fewer felt they had someone with whom to talk about the treatment (49% and 36%). The inpatient family members reported they could talk most frequently with general surgeons (40%) and family physicians (34%). Twenty-one per cent indicated there was no one with whom they could talk. The outpatient family members reported they could talk with family doctors (42%) and endocrinologists (24%). Twenty-seven per cent indicated they did not have anyone with whom they could talk.
Approximately two-thirds of the inpatient family members (62%) and half of the outpatient family members (53%) felt they had received a clear explanation of how radioactive iodine treatment works. Approximately 20% in both groups reported difficulty understanding treatment options and talking with health care professionals. The following comments reflect some of the difficulties:
For The majority of family members in both the inpatient (>77%) and outpatient (>83%) groups rated information about the patient's medical condition, tests and procedures, treatment choices, and side effects of treatments as important for them to know as a family member (see Table Two ). Two-thirds indicated topics such as emotional effects, diet and nutrition, preparing for hospitalization, and preparing one's home for the time after treatment were also important for family members to know. Within both family member groups, no more than about half of the respondents indicated they felt satisfied with the information they had received, with the exception of the information on treatment options (61%), the patient's medical condition (57%), and tests and procedures (57% 
Experiences during treatment
The family members who had a patient treated as an inpatient reported that 96% of the patients were isolated. About a third (34%) were isolated for one to two days and a half (53%) were isolated for three to four days. During the isolation, 63% of the patients were not allowed to have visitors and 25% were able to have limited visiting.
Forty-four per cent of the family members reported difficulty surrounding the patient's isolation as an inpatient. The difficulty arose from not being able to be close to the patient or feeling separated. From the perspective of the family member, the aspects of the experience that made it easier for them as a family member during the isolation interval were: knowing that the isolation was only for a few days (69%), being able to phone the patient (68%), being able to have a short visit with the patient (25%), and the interaction with the nurse (21%).
Precautions
Family members were asked to report on the precautions which were put into place upon the patients' return home. Table Three presents the list of precautions reported by the family members. The most frequently identified precautions for patients following treatment as an inpatient included flushing the toilet twice (75%), drinking lots of fluids (74%), and avoiding contact with children or pregnant women (72%). For the patients treated as an outpatient, the family members identified washing hands thoroughly (76%) and flushing the toilet twice (69%) most frequently.
The family members indicated they experienced difficulty with some aspects of the precautions. For family members of inpatients, the family members had difficulty with the patient being off thyroid medication before treatment (49%), with the patient being in hospital (47%), and not being able to get too close to the patient (44%). The family members of outpatients found it difficult not to get too close to the patient (21%), the patient being off medications (19%), and the person being isolated (15%). When patients were off their thyroid medication, family members had to cope with patients' mood swings, irritability, fatigue, and depression. In a few instances, the patients were instructed to remain in a room by themselves for a time at home.
Family members experienced concerns about the patient being at home after the radioactive iodine therapy. The largest proportion of family members in both the inpatient and the outpatient groups identified a concern about whether the treatment worked (82% and 76%). The next highest proportion identified a concern about how to know whether the radiation was gone from the home environment (54% and 45%). Some of the confusion family members experienced is indicated in the following comments:
When 
Impact of illness and treatment on family member
The family members reported experiencing a range of difficulties themselves during the interval of the radioactive iodine therapy. Anxiety was identified by more than half of the family members in the inpatient (62%) and the outpatient (52%) groups. Both groups identified the same types of issues including feeling apart from the patient, fear, and feeling down or depressed. When asked whether or not they had received adequate assistance for the problems that they had experienced, there was considerable variation in the number of individuals who felt they had received adequate help.
Support
Forty-four per cent of the family members in the inpatient group reported that they had felt the need to talk about issues related to the illness and the treatment. Of those who felt the need, 67% indicated they had someone with whom they could talk. Twenty-one per cent indicated they talked with another family member, while 13% spoke with their family physician. Two (3%) had seen a professional counsellor about issues concerning the patient's thyroid condition. Of the group who had not seen a counsellor, 22% indicated they would have liked to have seen someone. No one in this group had attended an educational or group session about thyroid disease. Twentynine per cent indicated they would have liked to have had that opportunity. As for the family members in the outpatient group, 57% indicated they had felt the need to talk with someone about the patient's thyroid disease. Of those who had felt the need to talk, 86% indicated they had someone with whom they could talk. Fifteen per cent indicated they could talk with other family members and 15% indicated they talked with their family physician. Three (5%) family members had been to see a professional counsellor regarding issues about the thyroid disease. Of those who had not seen a counsellor, 15% indicated they would have liked to have done so. Three (5%) individuals had also participated in an educational or group session about thyroid disease. Of those who had not attended such a session, 16% indicated they would have liked to have done so.
Discussion
This study was conducted to gather perspectives from family members of patients who had received I131. Family members are integral to the care of the patient, particularly in the home environment.
There are several limitations in this study. One limitation is the small convenience sample. The distribution of the surveys occurred according to the original plan and surveys were returned from all locations where they were distributed. Although the response rate actually exceeds those of general mailings without reminder notices, generalizability of the findings may be somewhat limited.
Another limitation, as is the case with all mailed surveys, is that those who returned the completed forms are likely those individuals with an interest in the topic or individuals who have the ability to read and articulate responses to a document such as the survey instrument. Thus, the findings may under-represent the views of individuals who are less educated and individuals who lack facility with English or French. This sample is also not reflective of the wide cultural and ethnic community within Canada.
Finally, the data are subject to recall bias because of the retrospective nature of the design. Although the majority of family members were recalling experiences that occurred within the last year, some were reflecting upon events of two-and-a-half to three years ago.
Despite the limitations, this is the first Canada-wide survey regarding the perspectives of family members of individuals who have received radioactive iodine treatment. Responses were received from all provinces in which distribution occurred, and included a good cross-section of community sizes. The results provide interesting insights and offer implications for future investigations. The data provide evidence that the disease and treatment of a close relative have an impact on the family member as well as on the patient.
The family members did not express the same level of satisfaction with access to information as did the patients in the companion study . This likely relates to their access to and interaction with health care professionals. They may have had to depend upon the patient to share and interpret information for them. Overall, they perceived information as important, yet they were less than satisfied with what they received across all topic areas. Similar findings have been reported in other work (Dow, Ferral, & Anello, 1997) . Clearly, there are implications in these observations for health care providers about communicating with family members and about providing written information regarding a range of topics related to radioactive iodine therapy. Many of the topics family members wanted to know more about were the same as those identified by patients (McGrath & Fitch) . The participation of nurses, nutritionists, and social workers on the teams providing care for patients receiving I131 and their respective family members could help with this information gap.
Many respondents in both the inpatient and the outpatient group indicated they felt informed about the disease and side effects and felt they had someone with whom they could talk about these matters. However, there were groups of respondents who did not have the explanations they felt they needed and did not have individuals with whom to talk. The challenge for health care providers is to be able to identify the individuals who need more information and find approaches to meet their needs.
At first glance, it is somewhat surprising that precautions were not reported as used by 100% of the respondents. However, the proportion of respondents citing the precautions used could reflect a number of factors: what was observed at the time, what the patient was told to do, what the family member remembers the patient doing, the policies in use at a particular institution, and the environmental reality (i.e., physical set-up in hospital). Also, there are variations in practices between inpatient and outpatient protocols. This variation possibly relates to the different dosage levels for patients with malignant disease and the amount of thyroid tissue the patient possesses. Nevertheless, there is a need for evidence-based guidelines regarding the precautions to be used in the home setting and sound educational strategies for sharing this information with patients and family members.
Of interest, many of the concerns family members expressed about the radioactive iodine therapy were the same as those expressed by patients (Kilpatrick, Kirstjanson, Tataryn, & Fraser, 1998; and family members in previous work (Wood, 1998) . Primarily, they worried about whether the radiation was gone from the home and whether the treatment worked. Both issues are difficult aspects for family members to assess or judge easily. Family members also experienced difficulties around the patient being off medication, the patient being away in hospital, and issues of not being able to get "too close" to the patient. In all likelihood, interventions could be developed to help both patients and family members with these concerns.
Family members reported experiencing their own difficulties during the radioactive iodine treatment. Many of the reported difficulties are indicative of psychosocial distress (i.e., anxiety, fear, feeling down) and have been reported by family members of cancer patients in previous work (Hilton, 1996; Kristjanson & Ashcroft, 1994; Northouse, Cracchiolo-Caraway, & Appel, 1991; Walker, 1997) . It is concerning that so few family members felt they received adequate help with these issues. It is unclear from the survey data whether family members were in contact with health care professionals regularly, whether the issues were identified by health care professionals, whether interventions were implemented, or whether interventions were not effective. Further work is needed to pinpoint the specific gaps in the care delivery process for family members.
Fairly large proportions of family members expressed the need to talk with someone about issues related to the disease and treatment. Although a sizable number of those individuals had someone with whom they could talk, a proportion did not have anyone. Very few family members had the opportunity to see a professional counsellor, attend a support or educational group, or access the Thyroid Foundation of Canada or the Canadian Cancer Society. These observations have implications for family education and providing information about community services.
Summary
This Canada-wide survey provided perspectives from family members of patients who received radioactive iodine therapy. Data indicate there is variation in family member perceptions about how precautions are to be implemented. Respondents expressed a desire for more information regarding many aspects of the treatment experience. Additionally, there are implications for support of family members in terms of dealing with psychosocial issues which emerge when an individual is living in the shadow of thyroid disease. doi:10.5737/1181912x134220224
